Drug Delivery Systems for Intraperitoneal Therapy

被引:0
作者
Gaurav Bajaj
Yoon Yeo
机构
[1] School of Pharmacy and Pharmaceutical Sciences,Department of Industrial and Physical Pharmacy
[2] Purdue University,Weldon School of Biomedical Engineering
[3] Purdue University,undefined
来源
Pharmaceutical Research | 2010年 / 27卷
关键词
hydrogels; intraperitoneal drug delivery; intraperitoneal malignancies; micro/nanoparticles; peritoneal adhesion;
D O I
暂无
中图分类号
学科分类号
摘要
Disorders associated with the peritoneal cavity include peritoneal adhesions and intraperitoneal (IP) malignancies. To prevent peritoneal adhesions, physical barrier devices are used to prevent organs from contacting other structures in the abdomen and forming adhesions, or pharmacological agents that interfere with adhesion formation are administered intraperitoneally. IP malignancies are other disorders confined to the peritoneal cavity, which are treated by combination of surgical removal and chemotherapy of the residual tumor. IP drug delivery helps in the regional therapy of these disorders by providing relatively high concentration and longer half-life of a drug in the peritoneal cavity. Various studies suggest that IP delivery of anti-neoplastic agents is a promising approach for malignancies in the peritoneal cavity compared to the systemic administration. However, IP drug delivery faces several challenges, such as premature clearance of a small molecular weight drug from the peritoneal cavity, lack of target specificity, and poor drug penetration into the target tissues. Previous studies have proposed the use of micro/nanoparticles and/or hydrogel-based systems for prolonging the drug residence time in the peritoneal cavity. This commentary discusses the currently used IP drug delivery systems either clinically or experimentally and the remaining challenges in IP drug delivery for future development.
引用
收藏
页码:735 / 738
页数:3
相关论文
共 50 条
[41]   Bacteria-responsive cytoderm drug delivery systems [J].
Zhou, Chenmeng ;
Zhang, Yue ;
Tian, Bo ;
Yu, Yue ;
Li, Dongxiao ;
Wu, Bingbing ;
Chang, Wenju ;
Shi, Tongguo ;
Xu, Fang ;
Bai, Jinyu ;
Wang, Chao .
BIOMATERIALS SCIENCE, 2025, 13 (10) :2744-2754
[42]   Cyclodextrins as eminent constituents in nanoarchitectonics for drug delivery systems [J].
Komiyama, Makoto .
BEILSTEIN JOURNAL OF NANOTECHNOLOGY, 2023, 14 :218-232
[43]   Hydrogels for Modified-release Drug Delivery Systems [J].
Zielinska, Aleksandra ;
Eder, Piotr ;
Rannier, Lucas ;
Cardoso, Juliana C. ;
Severino, Patricia ;
Silva, Amelia M. ;
Souto, Eliana B. .
CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (08) :609-618
[45]   Reservoir-Based Polymer Drug Delivery Systems [J].
Yang, Wan-Wan ;
Pierstorff, Erik .
JALA, 2012, 17 (01) :50-58
[46]   Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis [J].
Bruno, Maria Chiara ;
Cristiano, Maria Chiara ;
Celia, Christian ;
D'Avanzo, Nicola ;
Mancuso, Antonia ;
Paolino, Donatella ;
Wolfram, Joy ;
Fresta, Massimo .
ACS NANO, 2022, 16 (12) :19665-19690
[47]   Advances in Drug Delivery Systems for Atopic Dermatitis Treatment [J].
Yang, Jingyi ;
Jin, Ling ;
Li, Yuhao ;
Deng, Dan ;
Miao, Yuqing .
CHEMBIOCHEM, 2025, 26 (08)
[48]   Biomaterial Drug Delivery Systems for Prominent Ocular Diseases [J].
Sapowadia, Avin ;
Ghanbariamin, Delaram ;
Zhou, Libo ;
Zhou, Qifa ;
Schmidt, Tannin ;
Tamayol, Ali ;
Chen, Yupeng .
PHARMACEUTICS, 2023, 15 (07)
[49]   Fast responsive thermosensitive hydrogels as drug delivery systems [J].
Khorram, M ;
Vasheghani-Farahani, E ;
Ebrahimi, NG .
IRANIAN POLYMER JOURNAL, 2003, 12 (04) :315-322
[50]   Bioresponsive drug delivery systems for the treatment of inflammatory diseases [J].
Dou, Yin ;
Li, Chenwen ;
Li, Lanlan ;
Guo, Jiawei ;
Zhang, Jianxiang .
JOURNAL OF CONTROLLED RELEASE, 2020, 327 :641-666